initial public offerings (IPOs) trading on American exchanges

Thursday, January 27, 2022

Vaxxinity (VAXX) began trading on the Nasdaq on Thur 11 Nov 21

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States.
  • Sector(s): Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 89
  • Founded in 2014 
  • Headquartered in Dallas, Texas
Vaxxinity opened at $16.90 after pricing downsized 6.0 mln share IPO at $13/share, below the $14-$16 expected range

No comments:

Post a Comment